| [1] |
|
| [2] |
|
| [3] |
Marassi M, Fadini G P. The cardio-renal-metabolic connection: a review of the evidence[J]. Cardiovasc Diabetol, 2023, 22(1): 195. DOI: 10.1186/s12933-023-01937-x.
|
| [4] |
Ndumele C E, Rangaswami J, Chow S L, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association[J]. Circulation, 2023, 148(20): 1606-1635. DOI: 10.1161/cir.0000000000001184.
|
| [5] |
夏经钢,袁明霞,蔡晓凌, 等. 心血管-肾脏-代谢综合征患者的综合管理中国专家共识[J]. 中国心血管病研究, 2025, 23(3): 193-228.
|
| [6] |
Inker L A, Eneanya N D, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race[J]. N Engl J Med, 2021, 385(19): 1737-1749. DOI: 10.1056/nejmoa2102953.
|
| [7] |
Aggarwal R, Ostrominski J W, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020[J]. JAMA, 2024, 331(21): 1858-1860. DOI: 10.1001/jama.2024.6892.
|
| [8] |
|
| [9] |
尹经霞,余丽,蒲丹岚, 等. 《中国糖尿病防治指南(2024版)》解读[J]. 重庆医科大学学报, 2025, 50(5): 557-564.
|
| [10] |
Bull F C, Al-Ansari S S, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour[J]. Br J Sports Med, 2020, 54(24): 1451-1462. DOI: 10.1136/bjsports-2020-102955.
|
| [11] |
|
| [12] |
|
| [13] |
Stevens P E, Ahmed S B, Carrero J J, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int, 2024, 105(4): S117-S314. DOI: 10.1016/j.kint.2023.10.018.
|
| [14] |
Khan S S, Matsushita K, Sang Y Y, et al. Development and validation of the American Heart Association's PREVENT equations[J]. Circulation, 2024, 149(6): 430-449. DOI: 10.1161/circulationaha.123.067626.
|
| [15] |
He D J, Zhang X, Li C L, et al. Rising prevalence of cardiovascular-kidney-metabolic syndrome in China, 2010-2019 national cross-sectional surveys[J]. JACC, 2025, 86(3): 213-216. DOI: 10.1016/j.jacc.2025.05.030.
|
| [16] |
Zhu R X, Wang R, He J J, et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health[J]. JAMA Netw Open, 2024, 7(11): e2445309. DOI: 10.1001/jamanetworkopen.2024.45309.
|
| [17] |
Chen Y M, Wu X Y, Long T X, et al. Prevalence and mortality association of different stages of cardiovascular-kidney-metabolic syndrome[J]. JACC Adv, 2025, 4(6): 101843. DOI: 10.1016/j.jacadv.2025.101843.
|
| [18] |
Yim Y, Lee J E, Son Y, et al. Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011-2021: a representative longitudinal serial study[J]. Lancet Reg Heal West Pac, 2025, 55: 101474. DOI: 10.1016/j.lanwpc.2025.101474.
|
| [19] |
Johnston M C, Crilly M, Black C, et al. Defining and measuring multimorbidity: a systematic review of systematic reviews[J]. Eur J Public Health, 2019, 29(1): 182-189. DOI: 10.1093/eurpub/cky098.
|
| [20] |
Zhang C C, Xiao S J, Shi L, et al. Urban-rural differences in patterns and associated factors of multimorbidity among older adults in China: a cross-sectional study based on Apriori algorithm and multinomial logistic regression[J]. Front Public Health, 2021, 9: 707062. DOI: 10.3389/fpubh.2021.707062.
|
| [21] |
Tazzeo C, Zucchelli A, Vetrano D L, et al. Risk factors for multimorbidity in adulthood: a systematic review[J]. Ageing Res Rev, 2023, 91: 102039. DOI: 10.1016/j.arr.2023.102039.
|
| [22] |
Zhang Y B, Pan X F, Chen J X, et al. Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies[J]. J Epidemiol Community Health, 2021, 75(1): 92-99. DOI: 10.1136/jech-2020-214050.
|
| [23] |
Mure K, Tomono S, Mure M, et al. The combination of cigarette smoking and alcohol consumption synergistically increases reactive carbonyl species in human male plasma[J]. Int J Mol Sci, 2021, 22(16): 9043. DOI: 10.3390/ijms22169043.
|
| [24] |
Schultz W M, Hayek S S, Samman Tahhan A, et al. Marital status and outcomes in patients with cardiovascular disease[J]. J Am Heart Assoc, 2017, 6(12): e005890. DOI: 10.1161/JAHA.117.005890.
|
| [25] |
Sabia S, Dugravot A, Léger D, et al. Association of sleep duration at age 50, 60, and 70 years with risk of multimorbidity in the UK: 25-year follow-up of the Whitehall Ⅱ cohort study[J]. PLoS Med, 2022, 19(10): e1004109. DOI: 10.1371/journal.pmed.1004109.
|
| [26] |
Pan Y L, Bi J R, Feng L, et al. Sleep duration and cardiometabolic-kidney-metabolic syndrome: the role of depressive symptoms in a longitudinal study[J]. Nat Sci Sleep, 2025, 17: 1883-1893. DOI: 10.2147/NSS.S537555.
|
| [27] |
Li Y Z, Luo Z X, Zhang Z Y, et al. Socioeconomic status, depressive symptoms and cardiometabolic kidney syndrome: an analysis based on national representative data[J]. BMC Public Health, 2025, 25(1): 3916. DOI: 10.1186/s12889-025-25228-0.
|